Skip to main content
logo
Hansa Biopharma AB (publ) (STO:HNSA)
Sweden flag Sweden · Delayed Price · Currency is SEK
40.36
-0.66 (-1.61%)
Aug 13, 2026, 5:29 PM CET

Hansa Biopharma AB Ratios and Metrics

Millions SEK. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23
Market Cap
4,1743,4972,6581,380
Market Cap Growth
75.63%31.53%92.63%-
Enterprise Value
4,6553,7343,3321,380
Last Close Price
40.3634.3639.2026.20

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23
PS Ratio
22.0315.7315.52-
PB Ratio
-8.02-39.29-4.51-

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23
EV/Sales Ratio
24.5716.8019.45-

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23
Debt / Equity Ratio
-1.98-10.45-1.82-
Net Debt / Equity Ratio
--2.67-1.14-
Net Debt / EBITDA Ratio
-0.88-0.49-1.10-
Net Debt / FCF Ratio
-0.83-0.43-1.00-
Asset Turnover
0.170.230.43-
Inventory Turnover
11.5119.1264.03-
Quick Ratio
1.231.871.75-
Current Ratio
1.251.941.83-
Return on Equity (ROE)
247.90%157.36%273.72%-
Return on Assets (ROA)
-52.83%-53.16%-159.94%-
Return on Invested Capital (ROIC)
-80.99%-80.38%-117.49%-
Return on Capital Employed (ROCE)
-92.63%-80.04%-234.10%-

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23
Buyback Yield / Dilution
-42.70%-29.23%-19.59%-
Total Shareholder Return
-42.70%-29.23%-19.59%-